No Data
Bristol-Myers Squibb Notified Century Therapeutics On Dec 12 To Terminate Collaboration Agreement, Effective March 12, 2025; Co To Evaluate Opportunities In AML And Multiple Myeloma In The Context Of The Ongoing Strategic Review Of Century's...
Express News | Century Therapeutics - to Evaluate Opportunities in Aml and Multiple Myeloma
Express News | Century Therapeutics - Termination Effective March 12, 2025
Express News | Century Therapeutics- Bms Notified Co on Dec 12 to Terminate Collaboration Agreement With Century Therapeutics
Weekly Buzz: Tech stocks hit high scores on ominous day
Express News | Bristol-Myers Squibb Co Files for Mixed Shelf; Size Not Disclosed - SEC Filing
守株待鹅 : Goddess, which one are you Bullish on?